Authors: | Carrot-Zhang, J.; Yao, X.; Devarakonda, S.; Deshpande, A.; Damrauer, J. S.; Silva, T. C.; Wong, C. K.; Choi, H. Y.; Felau, I.; Robertson, A. G.; Castro, M. A. A.; Bao, L.; Rheinbay, E.; Liu, E. M.; Trieu, T.; Haan, D.; Yau, C.; Hinoue, T.; Liu, Y.; Shapira, O.; Kumar, K.; Mungall, K. L.; Zhang, H.; Lee, J. J. K.; Berger, A.; Gao, G. F.; Zhitomirsky, B.; Liang, W. W.; Zhou, M.; Moorthi, S.; Berger, A. H.; Collisson, E. A.; Zody, M. C.; Ding, L.; Cherniack, A. D.; Getz, G.; Elemento, O.; Benz, C. C.; Stuart, J.; Zenklusen, J. C.; Beroukhim, R.; Chang, J. C.; Campbell, J. D.; Hayes, D. N.; Yang, L.; Laird, P. W.; Weinstein, J. N.; Kwiatkowski, D. J.; Tsao, M. S.; Travis, W. D.; Khurana, E.; Berman, B. P.; Hoadley, K. A.; Robine, N.; TCGA Research Network; Meyerson, M.; Govindan, R.; Imielinski, M. |
Article Title: | Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway |
Abstract: | RTK/RAS/RAF pathway alterations (RPAs) are a hallmark of lung adenocarcinoma (LUAD). In this study, we use whole-genome sequencing (WGS) of 85 cases found to be RPA(−) by previous studies from The Cancer Genome Atlas (TCGA) to characterize the minority of LUADs lacking apparent alterations in this pathway. We show that WGS analysis uncovers RPA(+) in 28 (33%) of the 85 samples. Among the remaining 57 cases, we observe focal deletions targeting the promoter or transcription start site of STK11 (n = 7) or KEAP1 (n = 3), and promoter mutations associated with the increased expression of ILF2 (n = 6). We also identify complex structural variations associated with high-level copy number amplifications. Moreover, an enrichment of focal deletions is found in TP53 mutant cases. Our results indicate that RPA(−) cases demonstrate tumor suppressor deletions and genome instability, but lack unique or recurrent genetic lesions compensating for the lack of RPAs. Larger WGS studies of RPA(−) cases are required to understand this important LUAD subset. © 2021 The Authors Carrot-Zhang et al. perform whole-genome characterization of lung adenocarcinomas (LUADs) lacking RTK/RAS/RAF pathway alterations (RPAs) and identify mutations or structural variants in both coding and non-coding spaces that define a unique entity of RPA(−) LUADs and potentially explain the underlying biology of this disease. © 2021 The Authors |
Keywords: | genome analysis; oncogene; lung adenocarcinoma; tumor suppressor; tcga; structural variation; whole genome sequencing; driver; precision oncology; noncoding |
Journal Title: | Cell Reports |
Volume: | 34 |
Issue: | 5 |
ISSN: | 2211-1247 |
Publisher: | Cell Press |
Date Published: | 2021-02-02 |
Start Page: | 108707 |
Language: | English |
DOI: | 10.1016/j.celrep.2021.108707 |
PUBMED: | 33535033 |
PROVIDER: | scopus |
PMCID: | PMC8009291 |
DOI/URL: | |
Notes: | Article -- Export Date: 1 March 2021 -- Source: Scopus |